10-K Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001193125-18-042794`
Period End Date	20171231
Filing Date	20180213
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	nbix-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 111 Cash Flow Statement 104 Stockholders Equity 36

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$83.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$254.71M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$74.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$31.01M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments, available-for-sale	`AvailableForSaleSecuritiesCurrent`	$261.22M	USD	Point-in-time
Short-term investments, available-for-sale	`AvailableForSaleSecuritiesCurrent`	$224.08M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$31.13M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.86M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.09M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	86.88M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	88.79M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$554.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$310.44M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.81M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.27M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	88.79M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	86.88M	shares	Point-in-time
Long-term investments, available-for-sale	`AvailableForSaleSecuritiesNoncurrent`	$247.36M	USD	Point-in-time
Long-term investments, available-for-sale	`AvailableForSaleSecuritiesNoncurrent`	$43.49M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.88M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.50M	USD	Point-in-time
Total assets	`Assets`	$365.09M	USD	Point-in-time
Total assets	`Assets`	$817.59M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$53.52M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$26.18M	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	-	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$470.00K	USD	Point-in-time
Current portion of cease-use liability	`CeaseUseLiabilityCurrent`	$236.00K	USD	Point-in-time
Current portion of cease-use liability	`CeaseUseLiabilityCurrent`	$62.00K	USD	Point-in-time
Current portion of deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateCurrent`	$3.53M	USD	Point-in-time
Current portion of deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateCurrent`	$731.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$113.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$30.41M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$54.43M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$8.04M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$7.37M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$3.13M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$1.46M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$369.62M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	-	USD	Point-in-time
Cease-use liability	`CeaseUseLiabilityNoncurrent`	$617.00K	USD	Point-in-time
Cease-use liability	`CeaseUseLiabilityNoncurrent`	-	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$113.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$445.45M	USD	Point-in-time
Total liabilities	`Liabilities`	$50.21M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 88,793,903 and 86,883,300 at December 31, 2017 and 2016, respectively	`CommonStockValue`	$87.00K	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 88,793,903 and 86,883,300 at December 31, 2017 and 2016, respectively	`CommonStockValue`	$89.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.57B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.37B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.85M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-318.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.06B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.20B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$314.88M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$424.45M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$208.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$372.14M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$365.09M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$817.59M	USD	Point-in-time

Income Statement 111 line items

Line Item	Tag	Value	Unit	Period
Product sales, net	`SalesRevenueGoodsNet`	-	USD	Annual
Product sales, net	`SalesRevenueGoodsNet`	$116.63M	USD	Annual
Product sales, net	`SalesRevenueGoodsNet`	-	USD	Annual
Milestones and license fees	`LicensesRevenue`	$15.00M	USD	Annual
Milestones and license fees	`LicensesRevenue`	$19.77M	USD	Annual
Milestones and license fees	`LicensesRevenue`	$45.00M	USD	Annual
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	$15.00M	USD	Annual
Total revenues	`Revenues`	$60.77M	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	$94.52M	USD	1 Quarter
Total revenues	`Revenues`	$19.77M	USD	Annual
Total revenues	`Revenues`	$6.33M	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	$161.63M	USD	Annual
Total revenues	`Revenues`	$15.00M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$1.25M	USD	Annual
Cost of product sales	`CostOfGoodsSold`	-	USD	Annual
Cost of product sales	`CostOfGoodsSold`	-	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$121.83M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$81.49M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$94.29M	USD	Annual
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$32.48M	USD	Annual
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$169.91M	USD	Annual
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$68.08M	USD	Annual
Total operating expenses	`OperatingExpenses`	$162.37M	USD	Annual
Total operating expenses	`OperatingExpenses`	$46.25M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$79.93M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$63.60M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$66.77M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$113.97M	USD	Annual
Total operating expenses	`OperatingExpenses`	$41.83M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$292.99M	USD	Annual
Total operating expenses	`OperatingExpenses`	$82.68M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$38.44M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$35.86M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-94.20M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-131.36M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-147.37M	USD	Annual
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$3.33M	USD	Annual
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$2.12M	USD	Annual
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$3.42M	USD	Annual
Interest expense	`InterestExpense`	$19.52M	USD	Annual
Interest expense	`InterestExpense`	-	USD	Annual
Interest expense	`InterestExpense`	-	USD	Annual
Investment income, net	`InvestmentIncomeNet`	$6.24M	USD	Annual
Investment income, net	`InvestmentIncomeNet`	$2.84M	USD	Annual
Investment income, net	`InvestmentIncomeNet`	$1.93M	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$21.00K	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$20.00K	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-20.00K	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$6.28M	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$5.27M	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$-11.18M	USD	Annual
Net loss	`NetIncomeLoss`	$-59.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-142.54M	USD	Annual
Net loss	`NetIncomeLoss`	$-40.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-88.93M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-141.09M	USD	Annual
Net loss	`NetIncomeLoss`	$6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-44.66M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.90	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-1.05	USD	Annual
Basic	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-1.62	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-1.63	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.68	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-1.62	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.68	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.07	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-1.63	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-0.90	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-1.05	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	88.33M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	88.67M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	84.50M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	87.28M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	88.09M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	86.71M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	88.06M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	92.66M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.06M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	86.71M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.33M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	84.50M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	87.28M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.09M	shares	Annual
Net loss	`NetIncomeLoss`	$-59.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-142.54M	USD	Annual
Net loss	`NetIncomeLoss`	$-40.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-88.93M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-141.09M	USD	Annual
Net loss	`NetIncomeLoss`	$6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-44.66M	USD	1 Quarter
Net unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$659.00K	USD	Annual
Net unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-700.00K	USD	Annual
Net unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.53M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-89.63M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-140.43M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-144.07M	USD	Annual

Cash Flow Statement 104 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-59.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-142.54M	USD	Annual
Net loss	`NetIncomeLoss`	$-40.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-88.93M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-141.09M	USD	Annual
Net loss	`NetIncomeLoss`	$6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-44.66M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.40M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.01M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.45M	USD	Annual
Gain on sale of assets, net	`GainsLossesOnSalesOfAssets`	$3.33M	USD	Annual
Gain on sale of assets, net	`GainsLossesOnSalesOfAssets`	$2.10M	USD	Annual
Gain on sale of assets, net	`GainsLossesOnSalesOfAssets`	$3.43M	USD	Annual
Cease-use expense	`IncreaseDecreaseInCeaseUseExpense`	$-584.00K	USD	Annual
Cease-use expense	`IncreaseDecreaseInCeaseUseExpense`	$-85.00K	USD	Annual
Cease-use expense	`IncreaseDecreaseInCeaseUseExpense`	$-544.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$848.00K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$10.94M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	-	USD	Annual
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	-	USD	Annual
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$10.23M	USD	Annual
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$1.20M	USD	Annual
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$-294.00K	USD	Annual
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$-16.00K	USD	Annual
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-6.03M	USD	Annual
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.76M	USD	Annual
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.52M	USD	Annual
Non-cash share-based compensation expense	`ShareBasedCompensation`	$42.52M	USD	Annual
Non-cash share-based compensation expense	`ShareBasedCompensation`	$28.46M	USD	Annual
Non-cash share-based compensation expense	`ShareBasedCompensation`	$28.39M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$31.13M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$1.02M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	-	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	-	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$489.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$3.75M	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.79M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$9.84M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.40M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$27.34M	USD	Annual
Cease-use liability	`IncreaseDecreaseInCeaseUseLiability`	$-247.00K	USD	Annual
Cease-use liability	`IncreaseDecreaseInCeaseUseLiability`	$-610.00K	USD	Annual
Cease-use liability	`IncreaseDecreaseInCeaseUseLiability`	$-300.00K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	-	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-108.00K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-39.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-106.18M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-94.33M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-38.00M	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$449.05M	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$583.41M	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$298.78M	USD	Annual
Sales/maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$415.83M	USD	Annual
Sales/maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$255.12M	USD	Annual
Sales/maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$339.09M	USD	Annual
Deposits and restricted cash	`IncreaseDecreaseInRestrictedCash`	$-383.00K	USD	Annual
Deposits and restricted cash	`IncreaseDecreaseInRestrictedCash`	$92.00K	USD	Annual
Deposits and restricted cash	`IncreaseDecreaseInRestrictedCash`	$-40.00K	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$13.00K	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$7.00K	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$9.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.94M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.11M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.93M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$112.86M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-195.81M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-250.87M	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.39M	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.87M	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$276.99M	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$270.70M	USD	Point-in-time
Proceeds from issuance of senior convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of senior convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of senior convertible notes, net	`ProceedsFromConvertibleDebt`	$502.78M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$276.99M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.39M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$516.65M	USD	Annual
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$43.18M	USD	Annual
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$9.07M	USD	Annual
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$171.44M	USD	Annual
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$83.27M	USD	Point-in-time
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$254.71M	USD	Point-in-time
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$74.19M	USD	Point-in-time
Cash and cash equivalents at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$31.01M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$83.27M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$254.71M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$74.19M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$31.01M	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	Annual
Interest paid	`InterestPaid`	-	USD	Annual
Interest paid	`InterestPaid`	$6.24M	USD	Annual
Taxes paid	`IncomeTaxesPaid`	-	USD	Annual
Taxes paid	`IncomeTaxesPaid`	-	USD	Annual
Taxes paid	`IncomeTaxesPaid`	-	USD	Annual

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$314.88M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$424.45M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$208.70M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$372.14M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-59.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-142.54M	USD	Annual
Net loss	`NetIncomeLoss`	$-40.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-88.93M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-141.09M	USD	Annual
Net loss	`NetIncomeLoss`	$6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-44.66M	USD	1 Quarter
Unrealized gains (losses) on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$659.00K	USD	Annual
Unrealized gains (losses) on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-700.00K	USD	Annual
Unrealized gains (losses) on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.53M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.46M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$42.52M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.39M	USD	Annual
Issuance of common stock for restricted share units vested	`StockIssuedDuringPeriodValueShareBasedCompensation`	-	USD	Annual
Issuance of common stock for restricted share units vested	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.00K	USD	Annual
Issuance of common stock for restricted share units vested	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.00K	USD	Annual
Issuance of common stock for option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.86M	USD	Annual
Issuance of common stock for option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.30M	USD	Annual
Issuance of common stock for option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.39M	USD	Annual
Issuance of common stock for option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	341,000.00	shares	Annual
Issuance of common stock for option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.31M	shares	Annual
Issuance of common stock for option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.35M	shares	Annual
Issuance of common stock, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$270.69M	USD	Annual
Equity component of convertible debt, net of issuance costs	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$144.95M	USD	Annual
Ending balance	`StockholdersEquity`	$314.88M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$424.45M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$208.70M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$372.14M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.